Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase gene

Nordmann, 2002, Emerging carbapenemases in Gram‐negative aerobes, Clin Microbiol Infect, 8, 321, 10.1046/j.1469-0691.2002.00401.x Walsh, 2005, Metallo‐β‐lactamases: the quiet before the storm?, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005 Giakkoupi, 2003, Spread of integron‐associated VIM‐type metallo‐β‐lactamase genes among imipenem‐nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals, J Clin Microbiol, 41, 822, 10.1128/JCM.41.2.822-825.2003 Giakkoupi, 2003, VIM‐1 metallo‐β‐lactamase‐producing Klebsiella pneumoniae strains in Greek hospitals, J Clin Microbiol, 41, 3893, 10.1128/JCM.41.8.3893-3896.2003 Galani, 2005, Characterization of a new integron containing blaVIM‐1 and aac(6′)‐IIc in an Enterobacter cloacae clinical isolate from Greece, J Antimicrob Chemother, 55, 634, 10.1093/jac/dki073 Miriagou, 2003, Escherichia coli with a self‐transferable, multiresistant plasmid coding for metallo‐β‐lactamase VIM‐1, Antimicrob Agents Chemother, 47, 395, 10.1128/AAC.47.1.395-397.2003 Scoulica, 2004, Spread of blaVIM‐1‐producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM‐1 metallo‐β‐lactamase gene, Diagn Microbiol Infect Dis, 48, 167, 10.1016/j.diagmicrobio.2003.09.012 Sabbuba, 2003, Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract, J Clin Microbiol, 41, 4961, 10.1128/JCM.41.11.4961-4965.2003 NCCLS, 2000 Lee, 2003, Evaluation of Hodge test and the imipenem‐EDTA double‐disk synergy test for differentiating metallo‐β‐lactamase‐producing isolates of Pseudomonas spp. and Acinetobacter spp, J Clin Microbiol, 41, 4623, 10.1128/JCM.41.10.4623-4629.2003 Vatopoulos, 1990, Prevalence of a transferable SHV‐5 type β‐lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece, J Antimicrob Chemother, 26, 635, 10.1093/jac/26.5.635 Sambrook, 1989 Yan, 2001, Metallo‐β‐lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM‐3, a novel variant of the VIM‐2 enzyme, Antimicrob Agents Chemother, 45, 2224, 10.1128/AAC.45.8.2224-2228.2001 Levesque, 1995, PCR mapping of integrons reveals several novel combinations of resistance genes, Antimicrob Agents Chemother, 39, 185, 10.1128/AAC.39.1.185 Bradford, 2001, Extended‐spectrum β‐lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat, Clin Microbiol Rev, 14, 933, 10.1128/CMR.14.4.933-951.2001 Philippon, 2002, Plasmid‐determined AmpC‐type β‐lactamases, Antimicrob Agents Chemother, 46, 1, 10.1128/AAC.46.1.1-11.2002 Goering, 1998, The molecular epidemiology of nosocomial infection – an overview of principles, application, and interpretation, 131 Franceschini, 2000, Purification and biochemical characterization of the VIM‐1 metallo‐β‐lactamase, Antimicrob Agents Chemother, 44, 3003, 10.1128/AAC.44.11.3003-3007.2000